<DOC>
	<DOCNO>NCT01995708</DOCNO>
	<brief_summary>The purpose study see investigator help immune system work myeloma . This study see vaccine make alter dendritic cell make T cell work tumor cell . The stem cell collect transplant also use grow dendritic cell lab . The dendritic cell carry antigen . These cell inject skin . The investigator lab study vaccination find vaccine working .</brief_summary>
	<brief_title>CT7 , MAGE-A3 , WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells Consolidation Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Symptomatic multiple myeloma , ISS stag IIII , within 12 month start therapy . Completion induction therapy Very Good Partial Response ( VGPR ) , good , International Myeloma Working Group ( IMWG ) criterion . Deemed eligible ASCT standard institutional criterion . Age â‰¥18 year . Documentation CT7 , MAGEA3 , WT1 expression bone marrow and/or bone marrow aspirate . Prior autologous allogeneic SCT . Previous immunization CT7 , MAGEA3 , cancertestis antigen , WT1 . Known immunodeficiency , HIV positivity , hepatitis B , hepatitis C. History autoimmune disease ( e.g. , rheumatoid arthritis , SLE ) , vitiligo , diabetes , treat thyroiditis , allow . History severe allergic reaction vaccine unknown allergen . Participation clinical trial involve another investigational agent within 4 week prior first immunization . Lenalidomiderelated toxicity ASCT necessitate discontinuation part treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>CT7</keyword>
	<keyword>MAGE-A3</keyword>
	<keyword>WT1 mRNA-electroporated Autologous Langerhans</keyword>
	<keyword>vaccine</keyword>
	<keyword>Autologous Stem Cell Transplantation</keyword>
	<keyword>13-009</keyword>
</DOC>